© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
Kyle Wood, MD, reviews currently available treatment options for enteric hyperoxaluria and the importance of disease education.
June 30th 2021
Kyle Wood, MD, provides insight on the types of hyperoxaluria, the importance of disease education, and who should be screened for the disease.
August 1st 2021
An expert endourologist describes the prevalence and diagnostic processes of
enteric hyperoxaluria, as well as common challenges faced in making a diagnosis.
September 1st 2021
Kyle Wood, MD, comments on the presenting signs and symptoms of enteric hyperoxaluria and complications of untreated disease.
October 1st 2021
Kyle Wood, MD, reviews current therapies and strategies for the management of enteric hyperoxaluria.
November 1st 2021
An expert in endourology discusses concerns with currently available treatment options for enteric hyperoxaluria and comments on detecting the disease for patients with recurring stones.
December 1st 2021
Kyle Wood, MD, reviews data and clinical implications for the use of reloxaliase in enteric hyperoxaluria as seen in the phase 3 URIROX-1 trial and shares insight on additional ongoing trials.
January 1st 2022
Dr. Kyle Wood discusses optimal avenues to increase patient and provider education on enteric hyperoxaluria and provides closing thoughts on the future management of enteric hyperoxaluria.